According to OncoTherapy Science latest financial reports the company has an operating margin of -0.97%, an decrease of -45.21% to 2022. At the end of 2022 company had an operating margin of -1.78%.
Year | Operating Margin | Change |
---|---|---|
2023 | -0.97% | -45.21% |
2022 | -1.78% | -63.88% |
2021 | -4.93% | -28.86% |
2020 | -6.92% | - |